|
|
|
Insider
Information: |
Aldrich Richard |
Relationship: |
Director |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
444,838 |
|
Indirect Shares
|
12,959,539 |
|
|
Direct
Value |
$4,855,266 |
|
|
Indirect Value
|
$87,943,020 |
|
|
Total
Shares |
13,404,377 |
|
|
Total
Value |
$92,798,287 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
81.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Altus Pharmaceuticals Inc. |
ALTUQ |
Director |
2006-01-25 |
30,527 |
|
0 |
Premium* |
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2006-12-21 |
0 |
2006-12-21 |
3,662,662 |
Premium* |
|
Sequenom Inc |
SQNM |
10% Owner |
2008-06-06 |
0 |
2008-06-25 |
5,853,697 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-29 |
0 |
2008-10-29 |
1,081,410 |
Premium* |
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-10-30 |
0 |
2008-11-14 |
697,309 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2014-05-20 |
408,142 |
2014-05-20 |
299,294 |
Premium* |
|
Tempest Therapeutics, Inc |
TPST |
Director |
2018-12-07 |
6,169 |
2018-12-07 |
130,683 |
Premium* |
|
PTC Therapeutics, Inc. |
PTCT |
Director |
2015-06-08 |
0 |
2013-06-25 |
300,000 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2023-03-06 |
0 |
2023-03-06 |
0 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
Director |
2016-11-21 |
0 |
2017-10-12 |
934,484 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2023-03-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(254,877) |
0 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,400) |
0 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(342,100) |
0 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
358,500 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2022-06-06 |
4 |
B |
$4.75 |
$999,999 |
I/I |
210,526 |
210,526 |
2.1 |
% |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,125 |
342,100 |
0 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2018-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
755 |
6,169 |
0 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
14,558 |
81,220 |
0 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
11,709 |
66,662 |
0 |
- |
|
TPST |
Tempest Therapeutics, Inc |
Director |
|
2018-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,101 |
54,953 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-02-01 |
4 |
AS |
$19.99 |
$38,901 |
I/I |
(1,946) |
0 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-31 |
4 |
AS |
$20.78 |
$104,053 |
I/I |
(5,000) |
1,946 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-30 |
4 |
AS |
$21.33 |
$106,650 |
I/I |
(5,000) |
6,946 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-29 |
4 |
AS |
$21.36 |
$106,800 |
I/I |
(5,000) |
11,946 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-26 |
4 |
AS |
$20.46 |
$102,300 |
I/I |
(5,000) |
16,946 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-25 |
4 |
AS |
$20.22 |
$163,302 |
I/I |
(8,054) |
44,351 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-24 |
4 |
AS |
$19.83 |
$198,300 |
I/I |
(10,000) |
47,405 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-23 |
4 |
AS |
$19.67 |
$196,750 |
I/I |
(10,000) |
52,405 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-22 |
4 |
AS |
$19.54 |
$195,450 |
I/I |
(10,000) |
57,405 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-19 |
4 |
AS |
$19.65 |
$196,550 |
I/I |
(10,000) |
62,405 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-18 |
4 |
AS |
$19.36 |
$193,950 |
I/I |
(10,000) |
67,405 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-17 |
4 |
AS |
$18.95 |
$189,900 |
I/I |
(10,000) |
72,405 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-16 |
4 |
AS |
$19.26 |
$192,650 |
I/I |
(10,000) |
77,405 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-16 |
4 |
AS |
$19.08 |
$405,183 |
D/D |
(21,236) |
286,975 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2018-01-16 |
4 |
OE |
$2.88 |
$77,405 |
D/D |
21,236 |
308,211 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|